Brand · NIH DSLD
up&up magnesium labels
up&up files 1 on-market magnesium label; the magnesium salt is not named in the filed record for it, so the compound mass cannot be computed.
Composition across the portfolio · as filed
What up&up puts in the capsule besides magnesium
- 1 of 1 label lists magnesium stearate. Stearate is 4.1% magnesium by mass and that magnesium is not on the Supplement Facts line; the amount of stearate is not declared, so it cannot be quantified.
- 1 label uses a cellulose-based shell.
Label declarations · as filed
What up&up claims on its labels
Filed declarations across this brand's labels: 2 distinct filed entries across 1 NIH DSLD labels, counted 2026-09-13; these are manufacturer statements.
- Adult (18 - 50 Years) — on 1 of 1 label
- Gluten Free — on 1 of 1 label
What is not known · as of 2026-09-13
Gaps in the record for up&up
- 1 of 1 label does not name the magnesium salt in the filed record, so no compound mass can be computed for it.
- 1 of 1 label has no US retail listing matched as of 2026-09-13. That is a matching gap on our side, not evidence of unavailability.
Labels 1
| Magnesium 250 mgNIH DSLD · Label 19971 · Tablet or Pill | form not mapped yet | 250 mg | Not filed | — | Not tracked yet |
Forms filed
Compare within a form
These labels file no magnesium form text (form not mapped yet).
See all brands, all labels, or the priced form tables.
Filed composition facets
8 published excipient facets occur across 1 labels from up&up in the NIH DSLD records, counted 2026-09-13.
- calcium carbonate: 1 of 1 labels.
- citric acid: 1 of 1 labels.
- croscarmellose sodium: 1 of 1 labels.
- magnesium oxide: 1 of 1 labels.
- magnesium stearate: 1 of 1 labels.
- microcrystalline cellulose: 1 of 1 labels.
- stearic acid: 1 of 1 labels.
- talc: 1 of 1 labels.
Matching formulations across brands
1 published clusters include labels from up&up, matched by filed ingredients and serving structure on 2026-09-13.
- 250 mg per unit, rounded to 5 mg; 9 filed ingredients: 1 labels from this brand, 2 labels and 2 brands in the cluster.
FDA recall records for this firm
The FDA enforcement database holds 1 recall records naming up&up (queried 2026-09-13); 0 of them concern a magnesium product.
These are exact brand-string matches in the recalling-firm field or product description, including other products. A name match does not establish that two similarly named firms are the same legal entity. The recalling firm and recalled product are shown in each row.
| Report date | Class | Product described by FDA | Reason for recall | Status | openFDA record |
|---|---|---|---|---|---|
| 2014-01-15 | Class II | EstroPlus Maximum Strength Menopause Support Dietary Supplement in 28 count and 56 count blister strips under the following labels - CareOne Maximum Strength Multi Symptom Menopause Formula, 28 Caplets/Dietary Supplement; Meijer Maximum Strength Estroplus, Dietary Supplement, 28 Caplets; TopCare Maximum Strength Estroplus Dietary Supplement, 28 Caplets; Sunmark Estroplus Extra Strength, Dietary Supplement, 56 Caplets; Health Mart Pharmacy Extra Strength Estroplus, 56 Caplets Dietary Supplement; Up&Up Estroplus Dietary Supplement Maximum Strength 28 Caplets; CareOne Extra Strength Estroplus 56 Caplets/Dietary Supplement; Western Family Extra Strength Estroplus 56 Caplets, Meijer Extra Strength Estroplus Dietary Supplement 56 Caplets; Publix Extra Strength Estroplus 56 Caplets, Dietary Supplement; and TopCare Extra Strength Estroplus Dietary Supplement 56 Caplets. Recalling firm: Perrigo of SC. Description does not name a magnesium product. | Potential presence of Chloramphenicol contamination | Terminated | F-1384-2014 |
FDA assigns 3 recall classes by the assessed hazard, using the FDA classification definitions, checked 2026-09-13:
- Class I: Exposure to or use of the violating product carries a reasonable probability of serious harm to health or death.
- Class II: Exposure or use may produce temporary or medically reversible harm; the probability of serious harm is remote.
- Class III: Adverse health consequences from exposure or use are unlikely.
The FDA adverse event reporting system (CAERS) holds 21 reports naming up&up as of 2026-09-13. This is a count of submitted reports across all the firm's products; it is not an incidence rate and implies no causation.
The metric
What EC100 measures
EC100 = container price ÷ (elemental mg per serving × servings per container ÷ 100)
It normalizes the declared elemental amount to a 100 mg unit. It does not score ingredients, quality, or outcomes.